Cephalon's Frank Baldino - CEO Pay
Frank Baldino - Cephalon
Total Compensation: $14.5M
Details: In 2007, with an overall salary of $13.5 million, Baldino managed to pull down $2 million more than the previous year. The CEO--who's paid much more than those in his peer group--didn't manage such a hefty salary jump in 2008. With his total compensation rounding out to $14.5 million, Baldino's 2008 raise came in at just under $1 million last year. His salary included $63,750 for personal use of the company car, insurance, financial planning and medical reimbursements.
Cephalon News:
Cephalon hikes prices to fight generic
Cephalon finalizes $425M off-label settlement
FDA approves Cephalon's Treanda
FDA panel rejects broader Fentora use
FTC sues Cephalon for blocking generics
Cephalon, NitroMed make cuts jobs
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: